Altum’s AntiCovir Team

Ahmad Doroudian, PhD 

Chief Executive Officer & Director

Read About...
  • 20+ years experience as a Pharma CEO in finance, including M&A, and multiple IPOs, Integration of pharmaceutical operations (Whitehall Robbins, Rhone Polenc, Boehringer, Aventis)
  • Founder of Merus Labs (NASDAQ: MSLI), sold for $300 M+ in 2017
  • Acquisition, integration, tech transfer and management of branded pharmaceutical products Enablex®/Emselex®, Entrophen®, Sandomigran®, Sintrom®, Vancocin®, Zaditen®

Hooshmand Sheshbaradaran, PhD

Chief Operating Officer

Read About...
  • 30+ years senior pharma executive with experience in global drug development, marketing, business strategy, operations, licensing and M&A
  • Senior executive roles at Pharmacia/Pfizer, Roche, Zeneus/Cephalon, Niiki Pharma, Psioxus
  • Development of Camptosar®, Ellence®, Emcyt®, Sutent® and Vidaza®.

Angela Ogden, MD 

Chief Medical Officer

Read About...
  • 25+ year senior executive-level experience developing therapeutics from preclinical to launch including several blockbusters; plus 10+ years senior level academic medicine experience.
  • Senior executive roles at Pharmacia/Pfizer, BMS, JNJ, BTG
  • Development of Abraxane®, Aromasin®, Celebrex®, Dacogen®, Erbitux®, Folotyn®, TheraSphere®, Varithena®, Velcade®

Moira Ong, CPA, CA

Chief Financial Officer

Read About...
  • 18+ years experience as VP of Finance & CFO in several private and public companies including Merus Labs (NASDAQ: MSLI), BetterLife Pharma (CNSX: BETR; formerly Pivot Pharmaceuticals)
  • Managed the integration of the supply chain management and accounting Vancocin, Enablex®/Emselex®, acquired from Novartis, by Merus Labs International Inc.
  • Previously at Grant Thornton and Deloitte

Jeff Fellows 

Head of Regulatory

Read About...
  • 30+ years of drug development experience leading regulatory development efforts
  • Worked with early stage development companies and a large multinational biopharmaceutical enterprise developing programs across numerous therapeutic areas
  • Previously VP of Regulatory Affairs at Cell Therapeutics (currently CTI BioPharma, NASDAQ and MTA: CTIC), held senior positions in Regulatory Affairs at Amgen

Joseph Lamendola, PdD 

Regulatory Strategy Advisor

Read About...
  • 30+ years senior executive-level experience in pharma global regulatory from pre-IND to NDA
  • Senior executive roles at Schering Plough / Merck; Bristol-Myers Squibb
  • Filed and approved near 30 NDAs in ten different therapeutic areas

Scott Rudge, PdD 

CMC Head

Read About...
  • 30+ years senior executive-level experience in pharma global regulatory from pre-IND to NDA
  • Senior executive roles at Schering Plough / Merck; Bristol-Myers Squibb
  • Filed and approved near 30 NDAs in ten different therapeutic areas

Dawn East

Head Clinical Operations

Read About...
  • 30+ years senior executive-level experience in pharma global regulatory from pre-IND to NDA
  • Senior executive roles at Schering Plough / Merck; Bristol-Myers Squibb
  • Filed and approved near 30 NDAs in ten different therapeutic areas

Raj Dua, PhD

Head AP-002 CMC

Read About...
  • 30+ years senior executive-level experience in pharma global regulatory from pre-IND to NDA
  • Senior executive roles at Schering Plough / Merck; Bristol-Myers Squibb
  • Filed and approved near 30 NDAs in ten different therapeutic areas

Gary Camblin

Head Bioanalytics

Read About...
  • 30+ years senior executive-level experience in pharma global regulatory from pre-IND to NDA
  • Senior executive roles at Schering Plough / Merck; Bristol-Myers Squibb
  • Filed and approved near 30 NDAs in ten different therapeutic areas

Bianna Gal

QA-QC

Read About...
  • 20+ years of experience in quality assurance, compliance and validation
  • Previously Director of Quality Assurance at IRX Therapeutics and Pharmaceutical Product Assurance Senior Release Specialist at Pfizer